Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Syncona launches another cell therapy company, Treg specialist Quell

Focuses on novel immune system approach

Turning learning into action 2

Turning learning into action: The challenge of behaviour change

We all learn differently In order to optimise the sharing and acquisition of new knowledge, different modes of learning need to be leveraged. For example, the behaviourism, cognitivism and constructivism...

Porterhouse Medical Group

- PMLiVE

MorphoSys eyes 2020 launch for lymphoma CAR-T challenger

Results rival Kymriah and Yescarta - with less cost and complexity

- PMLiVE

There is no such thing as good medical communications

By Toby O'Brien

- PMLiVE

So far so good for Amgen’s much-anticipated KRAS inhibitor

Promise to hit previously 'undruggable' target

- PMLiVE

Genentech forges $800m autoimmune alliance with Parvus

Big vote of confidence in novel platform

- PMLiVE

After discount row, NICE finally says yes to first line Revlimid

England catches up with rest of Europe

- PMLiVE

Transitions in healthcare

By Dr Jonathan Reston

Lighthouse Medical Communications US continues its expansion with two new hires to its client services team

Anita Dudek joins Lighthouse’s client services team as an Account Director. Prior to joining Lighthouse, Anita led brand teams across oncology, respiratory, cardiovascular and diabetes therapeutic areas, as well as...

Lucid Group Communications Limited

- PMLiVE

Babylon expansion sparks ‘NHS destruction’ warnings

Necessary tech 'disruption' or cherrypicking?

- PMLiVE

Iovance up on good ASCO abstract data for cervical cancer therapy

Shares leap almost 20% after abstracts released

- PMLiVE

Venclexta plus Gazyva approval adds to non-chemo options in CLL

Joins Imbruvica combo in front line use

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links